Actively Recruiting

Age: 18Years +
All Genders
NCT05644548

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Led by Beijing Tongren Hospital · Updated on 2025-09-25

300

Participants Needed

1

Research Sites

356 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified. This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up. This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

CONDITIONS

Official Title

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with hypertension
  • Patients with diabetes
  • Patients with dyslipidemia
  • Agree to participate in this study
Not Eligible

You will not qualify if you...

  • Patients with malignant tumors
  • Patients with autoimmune diseases
  • Patients with immunodeficiency disease
  • Disagree to participate in this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Tongren Hospital

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

Y

Yu He, MD

CONTACT

M

Ma Jinbao, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here